Dr Susan Howard PhD CBiol MSB
Research Associate
- Email: sue.howard@manchester.ac.uk
- Telephone: 0161 275 1447
1.804 Stopford Building
The University of Manchester
Stopford Building
Oxford Road
Manchester
M13 9PT
Role
Post-doctoral research associate in Translational Medicine. Biological Safety Advisor and Deputy Chair of the Stopford GM/Biohazard Committee.
Memberships of Committees and Professional Bodies
European Society of Clinical Microbiology and Infectious Diseases (2010)
American Society for Microbiology (2006)
British Society for Antimicrobial Chemotherapy (2006)
Society of Biology (formerly Institute of Biology) – Chartered Biologist (2005)
Health Professions Council – state registered Clinical Scientist (2004)
Association for Clinical Biochemistry – Federation member (2001-2010)
British Society for Medical Mycology (2001)
Association of Clinical Microbiologists (2000-2010)
Research
My current research interests includes development of novel in vitro and in vivo models to investigate invasive aspergillosis, candidiasis and cryptococcosis, to aid further understanding of various antifungal agents and the optimisation of therapeutic outcomes.
Qualifications
PhD Medicine 2009 The University of Manchester
BSc (HONS) Applied Biology 1997 Staffordshire University
Selected publications
2011
- Howard, S. & Arendrup, M (2011). Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection. Med Mycol, 49 Suppl 1, S90-5. eScholarID:141791 | PMID:20795765 | DOI:10.3109/13693786.2010.508469
- Howard, S., Harrison, E., Bowyer, P., Varga, J. & Denning, D (2011). Cryptic species and azole resistance in the Aspergillus niger complex. Antimicrob Agents Chemother, 55(10), 4802-9. eScholarID:141797 | PMID:21768508 | DOI:10.1128/AAC.00304-11
- Howard, S., Lestner, J., Sharp, A., Gregson, L., Goodwin, J., Slater, J., Majithiya, J., Warn, P. & Hope, W (2011). Pharmacokinetics and pharmacodynamics of posaconazole for invasive pulmonary aspergillosis: clinical implications for antifungal therapy. J Infect Dis, 203(9), 1324-32. eScholarID:141807 | PMID:21357943 | DOI:10.1093/infdis/jir023
- Howard, S., Livermore, J., Sharp, A., Goodwin, J., Gregson, L., Alastruey-Izquierdo, A., Perlin, D., Warn, P. & Hope, W (2011). Pharmacodynamics of echinocandins against Candida glabrata: requirement for dosage escalation to achieve maximal antifungal activity in neutropenic hosts. Antimicrob Agents Chemother, 55(10), 4880-7. eScholarID:141805 | PMID:21807969 | DOI:10.1128/AAC.00621-11
2010
- Howard, S., Pasqualotto, A. & Denning, D (2010). Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis. Clin Microbiol Infect, 16(6), 683-8. eScholarID:141795 | PMID:19673966 | DOI:10.1111/j.1469-0691.2009.02911.x
2009
- Howard, S., Cerar, D., Anderson, M., Albarrag, A., Fisher, M., Pasqualotto, A., Laverdiere, M., Arendrup, M., Perlin, D. & Denning, D (2009). Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis, 15(7), 1068-76. eScholarID:141803 | PMID:19624922 | DOI:10.3201/eid1507.090043
2006
- Howard, S., Walker, S., Andrew, S., Borman, A., Johnson, E. & Denning, D (2006). Sub-cutaneous phaeohyphomycosis caused by Cladophialophora devriesii in a United Kingdom resident. Med Mycol, 44(6), 553-6. eScholarID:141808 | PMID:16966173 | DOI:10.1080/13693780600575627
- Howard, S., Webster, I., Moore, C., Gardiner, R., Park, S., Perlin, D. & Denning, D (2006). Multi-azole resistance in Aspergillus fumigatus. Int J Antimicrob Agents, 28(5), 450-3. eScholarID:141804 | PMID:17034993 | DOI:10.1016/j.ijantimicag.2006.08.017